查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1565662

基於唾液的篩檢市場，按類型、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Saliva-based Screening Market, By Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023 年基於唾液的篩檢市場規模為 3.509 億美元，2024 年至 2032 年複合年成長率為 8.20%。

唾液篩檢市場-市場動態

對方便、準確的診斷解決方案的需求不斷成長，推動了基於唾液的篩檢市場的成長

對方便、準確的診斷解決方案不斷成長的需求極大地推動了基於唾液的篩檢市場的成長。例如，美國食品藥物管理局(FDA) 在疫情期間批准了多項基於唾液的COVID-19 檢測，到2021 年底將授權超過800 萬項檢測用於緊急使用。 ) 強調與鼻拭子相比，這些測試的優點是易於使用並減少不適。此外，使用唾液進行基因檢測的進步（例如 23andMe 等公司開發的檢測）正在提高診斷準確性和消費者可近性。對非侵入性、方便用戶使用的測試方法的推動符合更廣泛的醫療保健趨勢，強調患者的舒適度和易用性，從而推動了市場的擴張。將基於唾液的測試納入日常健康監測和預防保健進一步支持了這種不斷成長的需求。

基於唾液的篩檢市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.20% 左右的複合年成長率成長

根據類型細分，聚合酶鍊式反應 (PCR) 預計將在 2023 年顯示最大的市場佔有率

從應用細分來看，2023年傳染病檢測為主導類型

按地區分類，北美是 2023 年的主要收入來源

基於唾液的篩檢市場細分分析：

全球唾液篩檢市場根據類型、應用、最終用戶和地區進行細分。

市場依類型分為四大類：酵素連結免疫吸附測定（ELISA）、聚合酶鏈反應（PCR）、側流測定（LFA）和生物感測器。聚合酶鍊式反應 (PCR) 因其高靈敏度和準確性而引領市場。接下來是酵素連結免疫吸附測定 (ELISA)，可在各種應用中提供可靠的檢測。側向層析分析 (LFA) 因其簡單性而廣受歡迎，而生物感測器則不斷湧現，具有創新功能。

市場根據應用分為四大類：傳染病檢測、藥物和酒精檢測、基因檢測和荷爾蒙檢測。由於對非侵入性檢測方法的高需求，傳染病檢測是主要應用。在個人化醫療進步的推動下，基因檢測隨之而來。藥物和酒精測試很重要，而荷爾蒙測試雖然很重要，但在基於唾液的診斷中不太普遍。

唾液篩檢市場-地理洞察

基於唾液的篩檢市場表現出顯著的地區差異，其中北美由於先進的醫療基礎設施和高採用率而處於領先地位。在美國，FDA 在大流行期間授權基於唾液的 COVID-19 檢測促進了廣泛使用，僅在 2022 年就進行了超過 600 萬次檢測。歐洲緊隨其後，英國和德國等國家將基於唾液的診斷納入其醫療保健系統。例如，英國國家醫療服務體系 (NHS) 已針對各種健康狀況納入唾液檢測，提高了診斷的可近性。由於對醫療保健技術的投資增加以及對非侵入性檢測方法的認知不斷提高，亞太地區，特別是日本和韓國，正在經歷快速成長。在日本，衛生部支持開發和使用基於唾液的診斷方法來管理慢性病。拉丁美洲、中東和非洲是新興市場，受到不斷擴大的醫療基礎設施和不斷增加的促進非侵入性診斷解決方案的公共衛生舉措的推動。

基於唾液的篩檢市場-競爭格局：

OraSure Technologies 等領先公司透過合作夥伴關係擴大了產品範圍，例如與比爾及梅琳達蓋茲基金會合作，以提高低收入國家基於唾液的愛滋病毒檢測的可及性。 PerkinElmer 在基於唾液的 COVID-19 診斷創新方面一直處於領先地位，收購了診斷公司 BioLegend 以增強其能力。此外，Spectrum Solutions 與伊利諾大學合作開發基於唾液的 COVID-19 檢測，幾個月內處理了超過 100 萬次檢測。 23andMe 繼續引領以唾液為基礎的基因檢測，透過與製藥公司合作進行研究，擴大其影響範圍。這些公司透過收購、合作和產品創新推動市場成長，提高唾液診斷的可及性和效率。

最新進展：

2024 年 8 月，Lord's Mark Microbiotech 計畫推出基於唾液的器官年齡測試，利用表觀遺傳學評估器官的生物學年齡。它的價格在 15,000 至 20,000 盧比之間，旨在提供個人化的健康見解並促進積極的醫療干預。

2021年7月，Bio Farma和Nusantics推出了使用漱口法的有限Bio Saliva COVID-19 PCR檢測測試。這種創新方法旨在簡化測試並提高可近性，從而加強管理和控制 COVID-19 傳播的努力。

目錄

第1章：基於唾液的篩檢市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的基於唾液的篩檢市場片段
    • 基於唾液的篩檢市場片段（按應用）
    • 最終用戶基於唾液的篩檢市場片段
    • 按國家/地區分類的基於唾液的篩檢市場片段
    • 按地區分類的基於唾液的篩檢市場片段
  • 競爭洞察

第 3 章：基於唾液的篩檢主要市場趨勢

  • 基於唾液的篩檢市場促進因素
    • 市場促進因素的影響分析
  • 基於唾液的篩檢市場限制
    • 市場限制影響分析
  • 基於唾液的篩檢市場機會
  • 唾液篩檢市場未來趨勢

第 4 章：基於唾液的篩檢產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：基於唾液的篩檢市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：基於唾液的篩檢市場格局

  • 2023 年基於唾液的篩檢市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：基於唾液的篩檢市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 酵素連結免疫吸附測定法 (ELISA)
    • 聚合酶鍊式反應 (PCR)
    • 側流層析 (LFA)
    • 生物感測器

第 8 章：基於唾液的篩檢市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 傳染病檢測
    • 藥物和酒精測試
    • 基因檢測
    • 荷爾蒙測試

第 9 章：基於唾液的篩檢市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診斷實驗室
    • 家庭護理設置
    • 研究所

第 10 章：基於唾液的篩檢市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美唾液篩檢主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲唾液篩檢主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區唾液篩檢主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲唾液篩檢主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 唾液篩檢中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 唾液篩檢產業

  • 競爭儀表板
  • 公司簡介
    • Abbott Laboratories
    • ALPCO Diagnostics
    • Bio-Rad Laboratories, Inc.
    • Diabetomics, Inc.
    • DNA Genotek Inc. (a subsidiary of OraSure)
    • F. Hoffmann-La Roche AG
    • Mawi DNA Technologies LLC
    • Miraculins Inc.
    • Oasis Diagnostics Corporation
    • Oranoxis, Inc.
    • OraSure Technologies, Inc.
    • PerkinElmer, Inc.
    • Quest Diagnostics Incorporated
    • Salimetrics, LLC
    • Thermo Fisher Scientific Inc.
    • ZRT Laboratory LLC
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3858

REPORT HIGHLIGHT

Saliva-based Screening Market size was valued at USD 350.90 Million in 2023, expanding at a CAGR of 8.20% from 2024 to 2032.

The Saliva-Based Screening Market focuses on diagnostic tests that use saliva samples for detecting various conditions, offering a non-invasive alternative to traditional methods. The market is expanding due to increasing demand for convenient and accurate diagnostic solutions. For example, during the COVID-19 pandemic, saliva-based tests gained prominence as they provided a less invasive method for large-scale testing, with over 10 million tests conducted globally in 2021. However, the market faces challenges such as variability in saliva sample quality and limited standardization across tests. Opportunities are emerging from advancements in saliva-based genetic testing and the development of new diagnostic assays for chronic diseases and infections. Additionally, the growing trend toward personalized medicine and increased funding for non-invasive diagnostic research are expected to drive further growth in this sector. The rise in preventive healthcare and self-testing also contributes to the expanding adoption of saliva-based screening solutions.

Saliva-based Screening Market- Market Dynamics

Increasing Demand for Convenient and Accurate Diagnostic Solutions Fuels Growth in Saliva-Based Screening Market

The increasing demand for convenient and accurate diagnostic solutions is significantly fueling growth in the Saliva-Based Screening Market. For instance, the U.S. Food and Drug Administration (FDA) approved several saliva-based COVID-19 tests during the pandemic, with over 8 million tests authorized for emergency use by late 2021. The Centers for Disease Control and Prevention (CDC) highlighted the benefits of these tests for their ease of use and reduced discomfort compared to nasal swabs. Furthermore, advancements in genetic testing using saliva, such as those developed by companies like 23andMe, are enhancing diagnostic accuracy and consumer accessibility. The push towards non-invasive, user-friendly testing methods aligns with broader healthcare trends emphasizing patient comfort and ease of use, driving the market's expansion. The integration of saliva-based tests into routine health monitoring and preventive care further supports this growing demand.

Saliva-based Screening Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.20% over the forecast period (2024-2032)

Based on Type segmentation, Polymerase Chain Reaction (PCR) was predicted to show maximum market share in the year 2023

Based on application segmentation, Infectious Disease Detection was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Saliva-based Screening Market- Segmentation Analysis:

The Global Saliva-based Screening Market is segmented on the basis of Type, Application, End-User, and Region.

The market is divided into four categories based on Type: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), and Biosensors. Polymerase Chain Reaction (PCR) leads the market due to its high sensitivity and accuracy. Enzyme-linked immunosorbent Assay (ELISA) follows, offering reliable detection in various applications. Lateral Flow Assay (LFA) is popular for its simplicity, while biosensors are emerging with innovative capabilities.

The market is divided into four categories based on application: Infectious Disease Detection, Drug and Alcohol Testing, Genetic Testing, and Hormonal Testing. Infectious disease detection is the leading application due to the high demand for non-invasive testing methods. Genetic testing follows, driven by advancements in personalized medicine. Drug and alcohol testing is significant, while hormonal testing, though important, is less prevalent in saliva-based diagnostics.

Saliva-based Screening Market- Geographical Insights

The Saliva-Based Screening Market exhibits notable regional differences, with North America leading due to advanced healthcare infrastructure and high adoption rates. In the U.S., the FDA's authorization of saliva-based COVID-19 tests during the pandemic facilitated widespread use, with over 6 million tests conducted in 2022 alone. Europe follows, with countries like the UK and Germany integrating saliva-based diagnostics into their healthcare systems. For example, the UK's National Health Service (NHS) has incorporated saliva tests for various health conditions, enhancing diagnostic accessibility. The Asia-Pacific region, particularly Japan and South Korea, is experiencing rapid growth due to increased investments in healthcare technology and rising awareness of non-invasive testing methods. In Japan, the Ministry of Health has supported the development and use of saliva-based diagnostics for chronic disease management. Latin America and the Middle East & Africa are emerging markets, driven by expanding healthcare infrastructure and increasing public health initiatives promoting non-invasive diagnostic solutions.

Saliva-based Screening Market- Competitive Landscape:

Leading companies like OraSure Technologies have expanded their product offerings through partnerships, such as their collaboration with the Bill & Melinda Gates Foundation to enhance the accessibility of saliva-based HIV testing in low-income countries. PerkinElmer has been at the forefront with innovations in saliva-based diagnostics for COVID-19, acquiring diagnostic company BioLegend to boost its capabilities. Additionally, Spectrum Solutions partnered with the University of Illinois to develop saliva-based testing for COVID-19, resulting in over 1 million tests being processed within months. 23andMe continues to pioneer saliva-based genetic testing, expanding its reach through collaborations with pharmaceutical companies for research purposes. These companies are driving market growth through acquisitions, partnerships, and product innovation, enhancing the accessibility and efficiency of saliva-based diagnostics.

Recent Developments:

In August 2024, Lord's Mark Microbiotech plans to launch a saliva-based organ age test, assessing the biological age of organs using epigenetics. Priced between Rs 15,000 and 20,000, it aims to provide personalized health insights and promote proactive healthcare interventions.

In July 2021, Bio Farma and Nusantics launched a limited Bio Saliva COVID-19 PCR detection test using a gargle method. This innovative approach aims to simplify testing and increase accessibility, enhancing efforts to manage and control the spread of COVID-19.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SALIVA-BASED SCREENING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • ALPCO Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Diabetomics, Inc.
  • DNA Genotek Inc. (a subsidiary of OraSure)
  • F. Hoffmann-La Roche AG
  • Mawi DNA Technologies LLC
  • Miraculins Inc.
  • Oasis Diagnostics Corporation
  • Oranoxis, Inc.
  • OraSure Technologies, Inc.
  • PerkinElmer, Inc.
  • Quest Diagnostics Incorporated
  • Salimetrics, LLC
  • Thermo Fisher Scientific Inc.
  • ZRT Laboratory LLC
  • Others

GLOBAL SALIVA-BASED SCREENING MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR)
  • Lateral Flow Assay (LFA)
  • Biosensors

GLOBAL SALIVA-BASED SCREENING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Disease Detection
  • Drug and Alcohol Testing
  • Genetic Testing
  • Hormonal Testing

GLOBAL SALIVA-BASED SCREENING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Homecare Settings
  • Research Institutes

GLOBAL SALIVA-BASED SCREENING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Saliva-based Screening Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Saliva-based Screening Market Snippet by Type
    • 2.1.2. Saliva-based Screening Market Snippet by Application
    • 2.1.3. Saliva-based Screening Market Snippet by End-User
    • 2.1.4. Saliva-based Screening Market Snippet by Country
    • 2.1.5. Saliva-based Screening Market Snippet by Region
  • 2.2. Competitive Insights

3. Saliva-based Screening Key Market Trends

  • 3.1. Saliva-based Screening Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Saliva-based Screening Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Saliva-based Screening Market Opportunities
  • 3.4. Saliva-based Screening Market Future Trends

4. Saliva-based Screening Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Saliva-based Screening Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Saliva-based Screening Market Landscape

  • 6.1. Saliva-based Screening Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Saliva-based Screening Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 7.1.3. Polymerase Chain Reaction (PCR)
    • 7.1.4. Lateral Flow Assay (LFA)
    • 7.1.5. Biosensors

8. Saliva-based Screening Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Infectious Disease Detection
    • 8.1.3. Drug and Alcohol Testing
    • 8.1.4. Genetic Testing
    • 8.1.5. Hormonal Testing

9. Saliva-based Screening Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Homecare Settings
    • 9.1.5. Research Institutes

10. Saliva-based Screening Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Saliva-based Screening Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Saliva-based Screening Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Saliva-based Screening Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Saliva-based Screening Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Saliva-based Screening Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Saliva-based Screening Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. ALPCO Diagnostics
    • 11.2.3. Bio-Rad Laboratories, Inc.
    • 11.2.4. Diabetomics, Inc.
    • 11.2.5. DNA Genotek Inc. (a subsidiary of OraSure)
    • 11.2.6. F. Hoffmann-La Roche AG
    • 11.2.7. Mawi DNA Technologies LLC
    • 11.2.8. Miraculins Inc.
    • 11.2.9. Oasis Diagnostics Corporation
    • 11.2.10. Oranoxis, Inc.
    • 11.2.11. OraSure Technologies, Inc.
    • 11.2.12. PerkinElmer, Inc.
    • 11.2.13. Quest Diagnostics Incorporated
    • 11.2.14. Salimetrics, LLC
    • 11.2.15. Thermo Fisher Scientific Inc.
    • 11.2.16. ZRT Laboratory LLC
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us